As economies around the globe slowly reopen, proactively mitigating the spread of the pandemic has been identified as the best way forward. This includes regular testing at home and at the office, both by individuals and organizations. Phosphorus, a trailblazing biotech company using genomics to improve human health, has been at the forefront of making reopening smooth sailing by developing at-home testing kits. These testing kits offer employers, consumers, and government agencies an increased capacity for COVID-19 testing. Based in New York, this company recently received FDA approval for its at-home saliva testing kits for COVID-19 and went on to launch them for mass use.
Facilitating the Safe Resumption of Operations
The at-home saliva test kits were approved through an intense round of validation studies after the company applied for an Emergency Use Authorization from the FDA. The company has the honor of producing only the second FDA-approved at-home unsupervised saliva test kit since the outbreak of the pandemic. According to Phosphorus Genomics, these test kits will go a long way in keeping the coronavirus from spreading further as businesses work on safely resuming operations.
How It Works
- The consumer or employer goes online to choose and order the test kits on the Phosphorus website.
- The consumer will be prompted to honestly fill out a medical questionnaire.
- The information provided in the questionnaire will be reviewed by an independent medical practitioner.
- If the independent medical practitioner approves the order, the sample collection kits will be sent to the consumer’s home or the employer’s address.
- Once you receive the sample collection kit, you will safely deposit your sample and send it back to the laboratory.
- The laboratory will test the sample and provide you with your results within 72 hours. You will also be provided with a consultation from an approved medical practitioner.
Designed for Ease of Use
Phosphorus Diagnostics pointed out that their at-home saliva testing kits for COVID-19 have been designed for ease of use. This is not only important in making sure that consumers safely collect and ship back their samples, but also motivates them to test more frequently. The alternative swab-based test methods have been discouraging for most consumers due to their complicated nature. However, the widespread use of the at-home saliva test kits is likely to see more people testing themselves regularly.
Liaising With Employers and Health Care Facilities
This biotech company has also launched an initiative to liaise with health care facilities and employers across the country to get as many people as possible tested with the at-home saliva testing kits. According to management, the goal of this initiative is to take mass testing to the next level as it is the best approach to mitigate the spread of the virus.
Leveraging Technology for Symptom and Exposure Assessment
Technology has emerged as the savior for many activities that brought to a halt by the pandemic, businesses shifting to operate online and embrace remote working. Phosphorus Genomics is also leveraging technology for its symptom and exposure assessment. It is going above and beyond to utilize technology for contact tracing and follow-up care navigation. All of this has been made possible thanks to its partnership with BioIQ, an industry-leading healthcare engagement and clinical adherence platform. Now, patients who test positive for COVID-19 will receive medical assistance and help with contact tracing to make sure that the virus does not spread further. Anyone found to be exposed will receive timely medical attention, which could be lifesaving.
About Phosphorus
This top-notch biotech company is on a mission to enhance human health by improving the understanding of the human genome and harnessing its power. It boasts a portfolio of the most comprehensive, outstanding, and cost-friendly genetic tests available today. Phosphorus Diagnostics studies promise medical advancements in cardiology, fertility, neurology, oncology, lipidology, pharmacogenetics, pediatrics, ophthalmology, and metabolic disorders.
